EMA Releases Guideline on Lupus Trials

Clinical Trials Advisor
A A
The European Medicines Agency has issued final guidance on clinical trial design for drugmakers developing targeted products to treat lupus — in an effort to encourage more companies to target the underserved disease.

To View This Article:

Login

Subscribe To Clinical Trials Advisor